SynthesisBMC cardiovascular disorders2025

SGLT2 inhibitors versus GLP-1 receptor agonists for major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.

Ali Abdelhaleem Omar Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.